Blackstone explores selling medical-grade skincare company ZO Skin Health. The deal could value the brand at approximately $2 billion. The process is in its early stages. There is no guarantee a transaction will be completed. Blackstone works with investment bankers from Citigroup and Raymond James to manage the potential sale.
Blackstone acquired a majority stake in the physician-dispensed skincare brand in October 2020 through its Tactical Opportunities fund. Dr. Zein Obagi founded ZO Skin Health in 2007. The brand sells globally through physicians and skincare professionals. A sale would allow Blackstone to capitalize on the brand's growth and deliver returns to its investors.